accesso®
("accesso" or the "Company")
Results of Annual General Meeting
accesso
The full text of the resolutions considered at the AGM is set out in the Notice of AGM published on
Results of the poll vote on each resolution are set out below:
|
Resolution |
For |
Against |
Withheld
|
|
|
1 |
To receive the Audited Financial Statements for the year ended
|
29,803,176 (100.00%) |
0 (0%) |
17,078 |
|
2 |
To approve the Annual Report on Remuneration for the financial year ended
|
27,425,945 (91.97%) |
2,393,484 (8.03%) |
825 |
|
3 |
Re-appoint
|
29,643,254 (99.41%) |
176,345 (0.59%) |
655 |
|
4 |
Re-appoint
|
29,649,001 (99.43%) |
170,598 (0.57%) |
655 |
|
5 |
Re-appoint
|
28,161,457 (94.46%) |
1,652,050 (5.54%) |
6,747 |
|
6 |
Re-appoint
|
29,555,462 (99.13%) |
258,045 (0.87%) |
6,747 |
|
7 |
Re-appoint
|
29,699,800 (99.60%) |
119,799 (0.40%) |
655 |
|
8 |
To appoint
|
29,819,585 (100.00%) |
14 (0.00%) |
655 |
|
9 |
To authorise the Directors to determine the Auditor's remuneration
|
29,819,599 (100.00%) |
0 (0.00%) |
655 |
|
10 |
To approve the rules of the Long Term Incentive Plan 2024
|
19,717,430 (71.13%) |
8,002,480 (28.87%) |
2,100,344 |
|
11 |
To renew the Directors' authority to allot securities
|
29,426,572 (98.68%) |
392,857 (1.32%) |
825 |
|
12 |
To waive shareholders' rights of pre-emption
|
28,849,455 (98.76%) |
360,853 (1.24%) |
1,543 |
|
13 |
To waive shareholders' rights of pre-emption in connection with an acquisition or specified capital investments
|
27,448,334 (93.97%) |
1,761,974 (6.03%) |
1,543 |
|
14 |
To authorise the Company to make market purchases of its own shares
|
29,811,594 (100.00%) |
0 (0.00%) |
8,660 |
The Board acknowledges the level of votes against resolution 10 and has engaged with its shareholders in order to understand the reasons behind the voting result and will continue to do so in the coming months. The Board takes seriously its responsibilities to represent the interests of shareholders and uphold the highest standards of corporate governance and is open to further constructive dialogue with shareholders and shareholder bodies.
For further information, please contact:
|
|
+44 (0)118 934 7400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Deutsche Numis (Nominated Adviser and Sole Broker) |
+44 (0)20 7260 1000 |
|
|
|
|
|
|
|
|
|
|
|
+44 (0)20 7550 9225 |
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the